ADAD1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

DNA lentivector for transduction information

Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression. This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions. GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, our 3rd Generation Packaging mixture. pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C. Vectors with selection markers like kanamycin, puromycin or cumate are available.
Lentiviral technical files
Lentivirus references
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Gene target

ADAD1 Lentiviral Vector EF1a pLenti-GIII-EF1a
Gene symbol

PLA2G3, ADAD1
Short name

ADAD1 Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a)
Technique

Vectors
Species

Human, Humans
Alternative name

adenosine deaminase domain containing 1 (testis-specific) Lentiviral integrating Desoxyribonucleic acid sequence (H. sapiens) (EF1a) (pLenti-GIII-EF1a)
Alternative to gene target

adenosine deaminase domain containing 1 (testis-specific), ADAD1 and IDBG-36845 and ENSG00000164113 and 132612, adenosine deaminase activity, nuclei, Adad1 and IDBG-140104 and ENSMUSG00000027719 and 21744, ADAD1 and IDBG-630374 and ENSBTAG00000046191 and 537320

Name

Artificial Gene Fusion
Concept

Scope note: The in vitro fusion of GENES by RECOMBINANT DNA techniques to analyze protein behavior or GENE EXPRESSION REGULATION, or to merge protein functions for specific medical or industrial uses.
Tree numbers
- E05.393.220.250
Qualifiers

drug effects, methods, radiation effects